Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.4, replacing the previous v3.5.3, indicating a frontend update.
    Difference
    0.1%
    Check dated 2026-05-16T09:30:19.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s displayed ClinicalTrials.gov revision/version updates from **v3.5.2** to **v3.5.3** without changing study details.
    Difference
    0.1%
    Check dated 2026-04-25T05:28:48.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:48:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T07:15:37.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:23:21.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    The page now includes an additional condition keyword 'Fallopian tube cancer' and a new resource link to the Genetic and Rare Diseases Information Center. The page revision is updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T02:25:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.